Matti Jauhiainen

Matti Jauhiainen

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2016 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
PLPirkka-Pekka Laurila
Pirkka-Pekka Laurila
JSJarkko Soronen
Jarkko Soronen
SKSander Kooijman
Sander Kooijman
SFSaara Forsström
Saara Forsström
MBMariëtte R. Boon
Mariëtte R. Boon
MJMatti Jauhiainen
Matti Jauhiainen
USF1 (upstream stimulatory factor 1) is a transcription factor associated with familial combined hyperlipidemia and coronary artery disease in humans. However, whether USF1 is beneficial or detrimental to cardiometabolic health has not been addressed. By inactivating USF1 in mice, we demonstrate protection against diet-induced dyslipidemia, obesity, insulin resistance, hepatic steatosis, and atherosclerosis. The favorable plasma lipid profile, including increased high-density lipoprotein cholesterol and decreased triglycerides, was coupled with increased energy expenditure due to activation of brown adipose tissue (BAT). Usf1 inactivation directs triglycerides from the circulation to BAT for combustion via a lipoprotein lipase–dependent mechanism, thus enhancing plasma triglyceride clearance. Mice lacking Usf1 displayed increased BAT-facilitated, diet-induced thermogenesis with up-regulation of mitochondrial respiratory chain complexes, as well as increased BAT activity even at thermoneutrality and after BAT sympathectomy. A direct effect of USF1 on BAT activation was demonstrated by an amplified adrenergic response in brown adipocytes after Usf1 silencing, and by augmented norepinephrine-induced thermogenesis in mice lacking Usf1. In humans, individuals carrying SNP (single-nucleotide polymorphism) alleles that reduced USF1 mRNA expression also displayed a beneficial cardiometabolic profile, featuring improved insulin sensitivity, a favorable lipid profile, and reduced atherosclerosis. Our findings identify a new molecular link between lipid metabolism and energy expenditure, and point to the potential of USF1 as a therapeutic target for cardiometabolic disease.

3 April 2012 in BMC Medical Genomics
Verified
Journal Article
Open access
PDF file
JSJarkko Soronen
Jarkko Soronen
PLPirkka-Pekka Laurila
Pirkka-Pekka Laurila
JNJussi Naukkarinen
Jussi Naukkarinen
ISIda Surakka
Ida Surakka
SRSamuli Ripatti
Samuli Ripatti
HYHannele Yki-Järvinen
Hannele Yki-Järvinen
To get insight into molecular mechanisms underlying insulin resistance, we compared acute in vivo effects of insulin on adipose tissue transcriptional profiles between obese insulin-resistant and lean insulin-sensitive women.

23 September 2010 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
NSNakanishi Shuhei
Nakanishi Shuhei
SSSanni Söderlund
Sanni Söderlund
MJMatti Jauhiainen
Matti Jauhiainen
MTMarja-Riitta Taskinen
Marja-Riitta Taskinen
Objectives: To study the resistance of HDL particles to direct oxidation in respect to the distribution of HDL particles. Design and Methods: We studied HDL composition, subclass distribution, and the kinetics of CuSO4-induced oxidation of total HDL and HDL3 in vitro in 36 low-HDL-C subjects and in 41 control subjects with normal HDL-C. Results: The resistance of HDL3 to oxidation, as assessed from the propagation rate was significantly higher than that of total HDL. The propagation rate and diene formation during HDL oxidation in vitro was attenuated in HDL derived from low-HDL-C subjects. Propagation rate and maximal diene formation during total HDL oxidation correlated significantly with HDL mean particle size. The propagation rate of total HDL oxidation in vitro displayed a significant positive association with HDL2 particle mass and HDL mean particle size by multiple regression analyses. Conclusions: These observations highlight that the distribution of HDL subpopulations has important implications for the potential of HDL as an anti-oxidant source.

6 February 2016 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
SHSanna Hellberg
Sanna Hellberg
JSJohanna M. U. Silvola
Johanna M. U. Silvola
MKMax Kiugel
Max Kiugel
HLHeidi Liljenbäck
Heidi Liljenbäck
OMOlli Metsälä
Olli Metsälä
ASAntti Saraste
Antti Saraste
Diabetes is a risk factor for atherosclerosis associated with oxidative stress, inflammation and cell proliferation. The purpose of this study was to evaluate arterial choline uptake and its relationship to atherosclerotic inflammation in diabetic and non-diabetic hypercholesterolemic mice. Low-density lipoprotein-receptor deficient mice expressing only apolipoprotein B100, with or without type 2 diabetes caused by pancreatic overexpression of insulin-like growth factor II (IGF-II/LDLR−/−ApoB100/100 and LDLR−/−ApoB100/100) were studied. Distribution kinetics of choline analogue 18F-fluoromethylcholine (18F-FMCH) was assessed in vivo by positron emission tomography (PET) imaging. Then, aortic uptakes of 18F-FMCH and glucose analogue 18F-fluorodeoxyglucose (18F-FDG), were assessed ex vivo by gamma counting and autoradiography of tissue sections. The 18F-FMCH uptake in atherosclerotic plaques was further compared with macrophage infiltration and the plasma levels of cytokines and metabolic markers. The aortas of all hypercholesterolemic mice showed large, macrophage-rich atherosclerotic plaques. The plaque burden and densities of macrophage subtypes were similar in diabetic and non-diabetic animals. The blood clearance of 18F-FMCH was rapid. Both the absolute 18F-FMCH uptake in the aorta and the aorta-to-blood uptake ratio were higher in diabetic than in non-diabetic mice. In autoradiography, the highest 18F-FMCH uptake co-localized with macrophage-rich atherosclerotic plaques. 18F-FMCH uptake in plaques correlated with levels of total cholesterol, insulin, C-peptide and leptin. In comparison with 18F-FDG, 18F-FMCH provided similar or higher plaque-to-background ratios in diabetic mice. Type 2 diabetes enhances the uptake of choline that reflects inflammation in atherosclerotic plaques in mice. PET tracer 18F-FMCH is a potential tool to study vascular inflammation associated with diabetes.

19 December 2012 in European Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
RBRobert M. Badeau
Robert M. Badeau
JMJari Metso
Jari Metso
PKPetri T. Kovanen
Petri T. Kovanen
MLMiriam Lee‐Rueckert
Miriam Lee‐Rueckert
MTMatti J. Tikkanen
Matti J. Tikkanen
MJMatti Jauhiainen
Matti Jauhiainen

19 April 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JPJanne Purhonen
Janne Purhonen
JRJayasimman Rajendran
Jayasimman Rajendran
MMMatthias Mörgelin
Matthias Mörgelin
KUKristiina Uusi-Rauva
Kristiina Uusi-Rauva
SKShintaro Katayama
Shintaro Katayama
JKJukka Kallijärvi
Jukka Kallijärvi
Mitochondrial disorders are among the most prevalent inborn errors of metabolism but largely lack treatments and have poor outcomes. High-fat, low-carbohydrate ketogenic diets (KDs) have shown beneficial effects in mouse models of mitochondrial myopathies, with induction of mitochondrial biogenesis as the suggested main mechanism. We fed KD to mice with respiratory chain complex III (CIII) deficiency and progressive hepatopathy due to mutated BCS1L, a CIII assembly factor. The mutant mice became persistently ketotic and tolerated the KD for up to 11 weeks. Liver disease progression was attenuated by KD as shown by delayed fibrosis, reduced cell death, inhibition of hepatic progenitor cell response and stellate cell activation, and normalization of liver enzyme activities. Despite no clear signs of increased mitochondrial biogenesis in the liver, CIII assembly and activity were improved and mitochondrial morphology in hepatocytes normalized. Induction of hepatic glutathione transferase genes and elevated total glutathione level were normalized by KD. Histological findings and transcriptome changes indicated modulation of liver macrophage populations by the mutation and the diet. These results reveal a striking beneficial hepatic response to KD in mice with mitochondrial hepatopathy and warrant further investigations of dietary modification in the management of these conditions in patients.